COMPANY REGISTRATION NUMBER: 3297916 CHARITY REGISTRATION NUMBER: 1086465
Cancer Black Care Company Limited by Guarantee Unaudited Financial Statements
31 March 2025
BAPTISTE & CO
Chartered Certified Accountants Tower 42, 25 Old Broad Street London EC2N 1HN
Cancer Black Care
Company Limited by Guarantee
Financial Statements
Year ended 31 March 2025
| Page | |
|---|---|
| Trustees' annual report (incorporating the director's report) | 1 |
| Independent examiner's report to the trustees | 4 |
| Statement of financial activities (including income and | |
| expenditure account) | 5 |
| Statement of financial position | 6 |
| Notes to the financial statements | 7 |
| The following pages do not form part of the financial statements | |
| Detailed statement of financial activities | 15 |
| Notes to the detailed statement of financial activities | 16 |
Cancer Black Care
Company Limited by Guarantee
Trustees' Annual Report (Incorporating the Director's Report)
Year ended 31 March 2025
The trustees, who are also the directors for the purposes of company law, present their report and the CancerBlackCare unaudited financial statements of the charity for the year ended 31 March 2025.
CancerBlackCare
Reference and administrative details
| Registered charity name | Cancer Black Care |
|---|---|
| Charity registration number | 1086465 |
| Company registration number | 3297916 |
| Principal office and registered | C/O 56 Redbridge Lane West |
| office | London |
| E11 2JU | |
| The trustees | |
| Professor F Chinegwundoh | |
| S During | |
| Dr I Llewellyn | |
| Independent examiner | Baptiste & Co |
| Tower 42, 25 Old Broad Street | |
| London EC2N 1HN |
CBC Chair Report for 2024/2025 Accounts
Cancer Black Care (CBC) continues to be a vital, community-rooted charity supporting individuals and families affected by cancer across Black, mixed and other ethnic minority communities. As we approach our 30th anniversary in 2026, our commitment remains the same, to provide culturally informed, compassionate and accessible cancer support that reflects the lived realities and specific needs of the people we serve.
This past year has marked significant growth and deeper impact. CBC has strengthened its governance, expanded its services and built strong partnerships that place us firmly at the forefront of tackling cancer inequalities. Our trustee board has continued to evolve, welcoming skilled professionals in HR, EDI and community leadership. This breadth of experience ensures CBC is guided by people who understand both strategic governance and the emotional, cultural and systemic challenges our communities face.
Under the leadership of our Chief Executive Officer, Paul Campbell, CBC has widened its reach, modernised internal systems and deepened collaborative work with statutory and voluntary partners. CBC is now increasingly recognised as a trusted voice in local, regional and national conversations on cancer equity and health inequalities.
- 1 -
Cancer Black Care
Company Limited by Guarantee
Trustees' Annual Report (Incorporating the Director's Report)
Year ended 31 March 2025
Partnerships have continued to be a core strength. Our work with Macmillan Cancer Support, Brent Integrated Care Board, Prostate Cancer Research, Prostate Cancer UK, The Cancer Awareness Trust and Movember has broadened access to support, boosted awareness and strengthened culturally sensitive cancer information in underserved communities.
As we move closer to our 30th year, CBC is refining its long-term strategy, enhancing its programmes and strengthening organisational readiness for future growth. Securing stable funding for our CEO and core team remains a priority, ensuring we have the capacity to meet rising demand and expand our reach.
The past year has highlighted both the strength of our community and the urgency of our mission. CBC remains committed to leading change, challenging inequality and providing a safe, culturally competent space for people affected by cancer. With continued investment, we are ready to deepen our impact in 2025 and beyond.
Key Achievements in 2024/2025
-
Formed national partnerships with Prostate Cancer UK, Prostate Cancer Research and the Cancer Awareness Trust.
-
Began building a national alliance with Can Survive UK and the Rose Thompson Foundation to strengthen culturally appropriate cancer care.
-
Delivered a major webinar for the European Association of Urology, speaking to hundreds of healthcare professionals across Europe.
-
Invited by His Majesty the King and Her Majesty the Queen to a Royal Reception at Buckingham Palace in recognition of CBC’s work tackling cancer inequalities.
-
Participated in the Government’s Ten-Year Cancer Plan discussions, ensuring Black and ethnic minority communities are represented at policy level.
-
Attended multiple House of Commons events to meet ministers and highlight cancer disparities.
-
Commissioned by the NHS to provide specialist training on how race and inequality affect cancer care, establishing CBC as a leading authority in this area.
- 2 -
Cancer Black Care
Company Limited by Guarantee
Trustees' Annual Report (Incorporating the Director's Report)
Year ended 31 March 2025
-
Featured in Movember’s Men’s Health Week activities at the House of Commons.
-
Delivered 12 out of 12 support group sessions in South London with the help of
dedicated volunteers.
-
Represented the United Kingdom at the European Association of Urology
-
Conference in Madrid.
Financial Sustainability
Despite challenging economic conditions, CBC has remained financially stable through careful planning and diverse income streams. Continued support from the Brent ICB, Macmillan Cancer Support and other partners has been crucial to our operations this year.
Future Objectives
Looking ahead, CBC will continue to build on its progress by:
-
Planning CBC’s 30th anniversary celebrations for 2026.
-
Recruiting additional trustees with skills in finance, fundraising and governance.
-
Securing large multi-year funding to support long-term growth.
-
Expanding training opportunities for partners on cancer disparities and cultural competence.
-
Securing a permanent office space to strengthen operational delivery.
-
Continuing to advocate for fair and equal cancer treatment access for ethnic minority communities.
We extend our thanks to our staff, volunteers, trustees, partners and, most importantly, the communities we serve. Your support enables us to continue delivering life-changing, culturally sensitive cancer care and advocacy.
CBC remains firmly committed to our mission and ready to build an even stronger future.
Professor F Chinegwundoh Trustee
- 3 -
Cancer Black Care
Company Limited by Guarantee
Independent Examiner's Report to the Trustees of Cancer Black Care
Year ended 31 March 2025
I report to the trustees on my examination of the financial statements of Cancer Black Care ('the charity') for the year ended 31 March 2025.
Responsibilities and basis of report
As the trustees of the company (and also its directors for the purposes of company law) you are responsible for the preparation of the financial statements in accordance with the requirements of the Companies Act 2006 ('the 2006 Act’).
Having satisfied myself that the accounts of the company are not required to be audited under Part 16 of the 2006 Act and are eligible for independent examination, I report in respect of my examination of the charity’s accounts as carried out under section 145 of the Charities Act 2011 (‘the 2011 Act’). In carrying out my examination I have followed the Directions given by the Charity Commission under section 145(5)(b) of the 2011 Act.
Independent examiner's statement
I have completed my examination. I confirm that no matters have come to my attention in connection with the examination giving me cause to believe:
-
accounting records were not kept in respect of the charity as required by section 386 of the 2006 Act; or
-
the financial statements do not accord with those records; or
-
the financial statements do not comply with the accounting requirements of section 396 of the 2006 Act other than any requirement that the accounts give a ‘true and fair' view which is not a matter considered as part of an independent examination; or
-
the financial statements have not been prepared in accordance with the methods and principles of the Statement of Recommended Practice for accounting and reporting by charities applicable to charities preparing their accounts in accordance with the Financial Reporting Standard applicable in the UK and Republic of Ireland (FRS 102).
I have no concerns and have come across no other matters in connection with the examination to which attention should be drawn in this report in order to enable a proper understanding of the accounts to be reached.
Independent Examiner Baptiste & Co Tower 42, 25 Old Broad Street London EC2N 1HN
- 4 -
Cancer Black Care
Company Limited by Guarantee
Statement of Financial Activities (including income and expenditure account)
Year ended 31 March 2025
| 2025 | 2024 | ||||
|---|---|---|---|---|---|
| Unrestricted | Restricted | ||||
| funds | funds | Total funds | Total funds | ||
| Note | £ | £ | £ | £ | |
| Income and endowments | |||||
| Donations and legacies | 5 | 3,209 | 123,039 | 126,248 | 118,399 |
| ----------------------- | -------------------------------- | -------------------------------- | -------------------------------- | ||
| Total income | 3,209 | 123,039 | 126,248 | 118,399 | |
| ======================= | ================================ | ================================ | ================================ | ||
| Expenditure | |||||
| Expenditure on charitable activities | 6,7 | 39 | 111,066 | 111,105 | 123,115 |
| Other expenditure | 8 | 1,260 | – | 1,260 | 1,260 |
| ----------------------- | -------------------------------- | -------------------------------- | -------------------------------- | ||
| Total expenditure | 1,299 | 111,066 | 112,365 | 124,375 | |
| ======================= | ================================ | ================================ | ================================ | ||
| ----------------------- | -------------------------------- | -------------------------------- | -------------------------------- | ||
| Net income/(expenditure) and net | |||||
| movement in funds | 1,910 | 11,973 | 13,883 | (5,976) | |
| ======================= | ================================ | ================================ | ================================ | ||
| Reconciliation of funds | |||||
| ---------------------------- | -------------------------------- | -------------------------------- | -------------------------------- | ||
| Total funds brought forward | 3,263 | 31,368 | 34,632 | 4,692 | |
| Prior year adjustment | 35,916 | ||||
| ---------------------------- | -------------------------------- | -------------------------------- | -------------------------------- | ||
| Total funds carried forward | 5,173 | 43,341 | 48,515 | 34,632 | |
| ============================ | ================================ | ================================ | ================================ |
The statement of financial activities includes all gains and losses recognised in the year. All income and expenditure derive from continuing activities.
The notes on pages 7 to 13 form part of these financial statements.
- 5 -
Cancer Black Care
Company Limited by Guarantee
Statement of Financial Position
31 March 2025
| 2025 | 2024 | |||
|---|---|---|---|---|
| Note | £ | £ | £ | |
| Fixed assets | ||||
| Tangible fixed assets | 12 | 1,488 | 1,984 | |
| Current assets | ||||
| Cash at bank and in hand | 47,027 | 32,648 | ||
| ---------------------------- | ---------------------------- | |||
| Net current assets | 47,027 | 32,648 | ||
| ---------------------------- | ---------------------------- | |||
| Total assets less current liabilities | 48,515 | 34,632 | ||
| ============================ | ============================ | |||
| Funds of the charity | ||||
| Restricted funds | 43,301 | 31,368 | ||
| Unrestricted funds | 5,173 | 3,263 | ||
| ---------------------------- | ---------------------------- | |||
| Total charity funds | 13 | 48,515 ============================ |
34,632 ============================ |
For the year ending 31 March 2025 the charity was entitled to exemption from audit under section 480 of the Companies Act 2006 relating to dormant companies.
Directors' responsibilities:
-
The members have not required the company to obtain an audit of its financial statements for the year in question in accordance with section 476;
-
The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of financial statements.
These financial statements were approved by the board of trustees and authorised for issue on 22 November 2025, and are signed on behalf of the board by:
Professor F Chinegwundoh Trustee
The notes on pages 7 to 13 form part of these financial statements.
- 6 -
Cancer Black Care
Company Limited by Guarantee
Notes to the Financial Statements
Year ended 31 March 2025
1. General information
The charity is a public benefit entity and a private company limited by guarantee, registered in England and Wales and a registered charity in England and Wales. The address of the registered office is C/O 56 Redbridge Lane West, London, E11 2JU.
2. Statement of compliance
These financial statements have been prepared in compliance with FRS 102, 'The Financial Reporting Standard applicable in the UK and the Republic of Ireland', the Statement of Recommended Practice applicable to charities preparing their accounts in accordance with the Financial Reporting Standard applicable in the UK and Republic of Ireland (FRS 102) (Charities SORP (FRS 102)) and the Companies Act 2006.
3. Accounting policies
Basis of preparation
The financial statements have been prepared on the historical cost basis, as modified by the revaluation of certain financial assets and liabilities and investment properties measured at fair value through income or expenditure.
The financial statements are prepared in sterling, which is the functional currency of the entity.
Going concern
There are no material uncertainties about the charity's ability to continue.
Fund accounting
Unrestricted funds are available for use at the discretion of the trustees to further any of the charity's purposes.
Designated funds are unrestricted funds earmarked by the trustees for particular future project or commitment.
Restricted funds are subjected to restrictions on their expenditure declared by the donor or through the terms of an appeal, and fall into one of two sub-classes: restricted income funds or endowment funds.
- 7 -
Cancer Black Care
Company Limited by Guarantee
Notes to the Financial Statements (continued)
Year ended 31 March 2025
3. Accounting policies (continued)
Incoming resources
All incoming resources are included in the statement of financial activities when entitlement has passed to the charity; it is probable that the economic benefits associated with the transaction will flow to the charity and the amount can be reliably measured. The following specific policies are applied to particular categories of income:
-
income from donations or grants is recognised when there is evidence of entitlement to the gift, receipt is probable and its amount can be measured reliably.
-
legacy income is recognised when receipt is probable and entitlement is established.
-
income from donated goods is measured at the fair value of the goods unless this is impractical to measure reliably, in which case the value is derived from the cost to the donor or the estimated resale value. Donated facilities and services are recognised in the accounts when received if the value can be reliably measured. No amounts are included for the contribution of general volunteers.
-
income from contracts for the supply of services is recognised with the delivery of the contracted service. This is classified as unrestricted funds unless there is a contractual requirement for it to be spent on a particular purpose and returned if unspent, in which case it may be regarded as restricted.
Resources expended
Expenditure is recognised on an accruals basis as a liability is incurred. Expenditure includes any VAT which cannot be fully recovered, and is classified under headings of the statement of financial activities to which it relates:
-
expenditure on raising funds includes the costs of all fundraising activities, events, noncharitable trading activities, and the sale of donated goods.
-
expenditure on charitable activities includes all costs incurred by a charity in undertaking activities that further its charitable aims for the benefit of its beneficiaries, including those support costs and costs relating to the governance of the charity apportioned to charitable activities.
-
other expenditure includes all expenditure that is neither related to raising funds for the charity nor part of its expenditure on charitable activities.
All costs are allocated to expenditure categories reflecting the use of the resource. Direct costs attributable to a single activity are allocated directly to that activity. Shared costs are apportioned between the activities they contribute to on a reasonable, justifiable and consistent basis.
Tangible assets
All fixed assets are initially recorded at cost.
- 8 -
Cancer Black Care
Company Limited by Guarantee
Notes to the Financial Statements (continued)
Year ended 31 March 2025
3. Accounting policies (continued)
Depreciation
Depreciation is calculated so as to write off the cost or valuation of an asset, less its residual value, over the useful economic life of that asset as follows:
Impairment of fixed assets
A review for indicators of impairment is carried out at each reporting date, with the recoverable amount being estimated where such indicators exist. Where the carrying value exceeds the recoverable amount, the asset is impaired accordingly. Prior impairments are also reviewed for possible reversal at each reporting date.
For the purposes of impairment testing, when it is not possible to estimate the recoverable amount of an individual asset, an estimate is made of the recoverable amount of the cashgenerating unit to which the asset belongs. The cash-generating unit is the smallest identifiable group of assets that includes the asset and generates cash inflows that largely independent of the cash inflows from other assets or groups of assets.
For impairment testing of goodwill, the goodwill acquired in a business combination is, from the acquisition date, allocated to each of the cash-generating units that are expected to benefit from the synergies of the combination, irrespective of whether other assets or liabilities of the charity are assigned to those units.
Financial instruments
A financial asset or a financial liability is recognised only when the charity becomes a party to the contractual provisions of the instrument.
Basic financial instruments are initially recognised at the amount receivable or payable including any related transaction costs.
Current assets and current liabilities are subsequently measured at the cash or other consideration expected to be paid or received and not discounted.
Debt instruments are subsequently measured at amortised cost.
Where investments in shares are publicly traded or their fair value can otherwise be measured reliably, the investment is subsequently measured at fair value with changes in fair value recognised in income and expenditure. All other such investments are subsequently measured at cost less impairment.
Other financial instruments, including derivatives, are initially recognised at fair value, unless payment for an asset is deferred beyond normal business terms or financed at a rate of interest that is not a market rate, in which case the asset is measured at the present value of the future payments discounted at a market rate of interest for a similar debt instrument.
- 9 -
Cancer Black Care
Company Limited by Guarantee
Notes to the Financial Statements (continued)
Year ended 31 March 2025
3. Accounting policies (continued)
Financial instruments (continued)
Other financial instruments are subsequently measured at fair value, with any changes recognised in the statement of financial activities, with the exception of hedging instruments in a designated hedging relationship.
Financial assets that are measured at cost or amortised cost are reviewed for objective evidence of impairment at the end of each reporting date. If there is objective evidence of impairment, an impairment loss is recognised under the appropriate heading in the statement of financial activities in which the initial gain was recognised.
For all equity instruments regardless of significance, and other financial assets that are individually significant, these are assessed individually for impairment. Other financial assets are either assessed individually or grouped on the basis of similar credit risk characteristics.
Any reversals of impairment are recognised immediately, to the extent that the reversal does not result in a carrying amount of the financial asset that exceeds what the carrying amount would have been had the impairment not previously been recognised.
4. Limited by guarantee
The liability of each member is restricted to £10.
5. Donations and legacies
| YEAR TO 31/03/2025 | Unrestricted | Restricted | Total Funds |
|---|---|---|---|
| Funds | Funds | 2025 | |
| £ | £ | £ | |
| Donations | |||
| Donations | 3,209 | – | 3,209 |
| Grants | |||
| NHS NWL | – | 44,456 | 44,456 |
| Macmillan Cancer Relief | – | 78,583 | 78,583 |
| ----------------------- | -------------------------------- | -------------------------------- | |
| 3,209 | 123,039 | 126,248 | |
| ======================= | ================================ | ================================ | |
| YEAR TO 31/03/2024 | Unrestricted | Restricted | Total Funds |
| Funds | Funds | 2024 | |
| £ | £ | £ | |
| Donations | |||
| Donations | 870 | – | 870 |
| Grants | |||
| BCCG | – | 117,529 | 117,529 |
| -------------- | -------------------------------- | -------------------------------- | |
| 870 | 117,529 | 118,399 | |
| ============== | ================================ | ================================ |
- 10 -
Cancer Black Care
Company Limited by Guarantee
Notes to the Financial Statements (continued)
Year ended 31 March 2025
6. Expenditure on charitable activities by fund type
| YEAR TO 31/03/2025 | Unrestricted | Restricted | Total Funds |
|---|---|---|---|
| Funds | Funds | 2025 | |
| £ | £ | £ | |
| Delivery of services | – | 111,066 | 111,066 |
| Support costs | 39 | – | 39 |
| -------------- | -------------------------------- | -------------------------------- | |
| 39 | 111,066 | 111,105 | |
| ============== | ================================ | ================================ | |
| Wages and salaries | 99,631 | 100,868 | |
| Telephone | 1,950 | 2,175 | |
| Other office costs | 8,989 | 19,573 | |
| Depreciation | 496 | 436 | |
| Other interest payable and similar charges | 39 | 63 | |
| -------------------------------- | -------------------------------- | ||
| 111,105 | 123,115 | ||
| -------------------------------- | -------------------------------- | ||
| YEAR TO 31/03/2024 | Unrestricted | Restricted | Total Funds |
| Funds | Funds | 2024 | |
| £ | £ | £ | |
| Delivery of services | – | 123,053 | 123,052 |
| Support costs | 63 | – | 63 |
| -------------- | -------------------------------- | -------------------------------- | |
| 63 ============== |
123,053 ================================ |
123,115 ================================ |
7. Expenditure on charitable activities by activity type
| Activities | ||||
|---|---|---|---|---|
| undertaken | Support | Total funds | Total fund | |
| directly | costs | 2025 | 2024 | |
| £ | £ | £ | £ | |
| Delivery of services | 111,066 | – | 111,066 | 123,052 |
| Governance costs | – | 39 | 39 | 63 |
| -------------------------------- | -------------- | -------------------------------- | -------------------------------- | |
| 111,066 | 39 | 111,105 | 123,115 | |
| ================================ | ============== | ================================ | ================================ | |
| Other expenditure | ||||
| Unrestricted | Total Funds | Unrestricted | Total Funds | |
| Funds | 2025 | Funds | 2024 | |
| £ | £ | £ | £ | |
| Accounting fees - independent | ||||
| examination | 1,260 | 1,260 | 1,260 | 1,260 |
| ======================= | ======================= | ======================= | ======================= | |
| Net income/(expenditure) | ||||
| Net income/(expenditure) is stated after | charging/(crediting): | |||
| 2025 | 2024 | |||
| £ | £ | |||
| Depreciation of tangible fixed assets | 496 ============== |
436 ============== |
8. Other expenditure
9. Net income/(expenditure)
- 11 -
Cancer Black Care
Company Limited by Guarantee
Notes to the Financial Statements (continued)
Year ended 31 March 2025
10. Staff costs
| The total staff costs and employee benefits for the reporting period are analysed as | The total staff costs and employee benefits for the reporting period are analysed as | follows: |
|---|---|---|
| 2025 | 2024 | |
| £ | £ | |
| Wages and salaries | 99,631 ============================ |
100,868 ================================ |
The average head count of employees during the year was 2 (2024: 2).
No employee received employee benefits of more than £60,000 during the year (2024: Nil).
11. Trustee remuneration and expenses
There was no trustees' remuneration.
12. Tangible fixed assets
| Fixtures and | |||
|---|---|---|---|
| fittings | Equipment | Total | |
| £ | £ | £ | |
| Cost | |||
| At 1 April 2024 and 31 March 2025 | 76,032 | 11,948 | 87,980 |
| ============================ | ============================ | ============================ | |
| Depreciation | |||
| At 1 April 2024 | 75,356 | 10,640 | 85,996 |
| Charge for the year | 327 | 169 | 496 |
| ---------------------------- | ---------------------------- | ---------------------------- | |
| At 31 March 2025 | 75,683 | 10,809 | 86,492 |
| ============================ | ============================ | ============================ | |
| Carrying amount | |||
| At 31 March 2025 | 349 | 1,139 | 1,488 |
| ============================ | ============================ | ============================ | |
| At 31 March 2024 | 676 | 1,308 | 1,984 |
| ============================ | ============================ | ============================ |
- 12 -
Cancer Black Care
Company Limited by Guarantee
Notes to the Financial Statements (continued)
Year ended 31 March 2025
13. Analysis of charitable funds Unrestricted funds
| at | at | ||
|---|---|---|---|
| 01/04/24 | income | Expenditure | 31/03/25 |
| 3,263 | 3,209 | 1,299 | 5,173 |
Restricted funds
| at | at | ||
|---|---|---|---|
| 01/04/24 | income | Expenditure | 31/03/25 |
| 31,368 | 123,039 | 111,066 | 43,341 |
- 13 -
Cancer Black Care
Company Limited by Guarantee
Management Information
Year ended 31 March 2025
The following pages do not form part of the financial statements.
- 14 -
Cancer Black Care
Company Limited by Guarantee
Detailed Statement of Financial Activities
Year ended 31 March 2025
| 2025 | 2024 | |
|---|---|---|
| £ | £ | |
| Income and endowments | ||
| Donations and legacies | ||
| Donations | 3,209 | 870 |
| Grants receivable - NHS NWL | 44,456 | – |
| Grants receivable - Macmillan Cancer Relief | 78,583 | – |
| Grants receivable - BCCG | – | 117,529 |
| -------------------------------- | -------------------------------- | |
| 126,248 | 118,399 | |
| -------------------------------- | -------------------------------- | |
| -------------------------------- | -------------------------------- | |
| Total income | 126,248 | 118,399 |
| ================================ | ================================ | |
| Expenditure | ||
| Expenditure on charitable activities | ||
| Wages and salaries | 99,631 | 100,868 |
| Telephone | 1,950 | 2,175 |
| Other office costs | 8,989 | 19,573 |
| Depreciation | 496 | 436 |
| Other interest payable and similar charges | 39 | 63 |
| -------------------------------- | -------------------------------- | |
| 111,105 | 123,115 | |
| -------------------------------- | -------------------------------- | |
| Other expenditure | ||
| Accounting fees - independent examination | 1,260 | 1,260 |
| ----------------------- | ----------------------- | |
| -------------------------------- | -------------------------------- | |
| Total expenditure | 112,365 | 124,375 |
| ================================ | ================================ | |
| -------------------------------- | -------------------------------- | |
| Net income/(expenditure) | 13,883 | (5,976) |
| ================================ | ================================ |
- 15 -
Cancer Black Care
Company Limited by Guarantee
Notes to the Detailed Statement of Financial Activities
Year ended 31 March 2025
| 2025 | 2024 | |
|---|---|---|
| £ | £ | |
| Expenditure on charitable activities | ||
| Delivery of services | ||
| Activities undertaken directly | ||
| Wages and salaries | 99,631 | 100,868 |
| Telephone | 1,950 | 2,175 |
| Other office costs | 8,989 | 19,573 |
| Depreciation | 496 | 436 |
| -------------------------------- | -------------------------------- | |
| 111,066 | 123,052 | |
| -------------------------------- | -------------------------------- | |
| Governance costs | ||
| Bank charges and interest payable | 39 | 63 |
| -------------- | -------------- | |
| -------------------------------- | -------------------------------- | |
| Expenditure on charitable activities | 111,105 | 123,115 |
| ================================ | ================================ |
- 16 -